Ahmedabad: The state health department announced on Thursday that new pricing guidelines for cardiac stents used in ...
Avisi Technologies, a clinical-stage ophthalmic device company, today announced encouraging six‐month interim results from the VITA trial evaluating its VisiPlate® device, an ultrathin, multichannel ...
Background The patency of intracranial stents may not be reliably assessed with either CT angiography or MR angiography due to imaging artifacts. We investigated the potential of ultra-high resolution ...
The development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion, especially within 30 ...
MALVERN, Pa., March 12, 2025 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new series of AEC-Q200 qualified Power Metal Strip ® shunt resistors with industry-low ...
Implantation of drug-eluting stents (DESs) remains central to percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) and chronic coronary syndromes (CCS). DES platforms, polymers ...
Methods: We retrospectively reviewed records of 55 patients diagnosed with idiopathic NPH (INPH) and treated with CSF shunts, all of whom were followed for more than 3 years after the original shunt ...
Introduction The LVIS stent system (LVIS and LVIS Junior) is a self-expanding, retrievable, microstent system indicated for the treatment of wide-necked cerebral aneurysms (WNAs). The present pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results